ClinicalTrials.govpublic full text
VEGF Concentrations After Intravitreal Bevacizumab vs Ranibizumab as a Treatment for Type 1 ROP
retinopathy of prematurity both eyes, retinal disease, premature birth, eye diseases, retinopathy of prematurity, vegf, bevacizumab, ranibizumab, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 967510
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.